The purpose of this review is to update, present some of the new data on, and outline the controversies regarding neoadjuvant and adjuvant therapy of esophagogastric junction and gastric adenocarcinoma.
Steven Sandler, MD
Advertisement
Articles by Steven Sandler, MD
Advertisement
Latest Updated Articles
Esophagogastric Junction and Gastric Adenocarcinoma: Neoadjuvant and Adjuvant Therapy, and Future DirectionsPublished: June 15th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Casdatifan Monotherapy Achieves Clinical Activity in Late-Line Kidney Cancer
2
Antiemetic Regimen Limits Chemo-Induced Nausea/Vomiting in Multiple Myeloma
3
The Essential Role of Clinical Social Work in Oncology
4
Intravesical Mitomycin Produces Enduring Efficacy Across NMIBC Trials
5
